Expanded Access of Imvotamab (IGM-2323) in Patients With R/R NHL
Clinical trial NCT06331832 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT06331832
- Sponsor
- IGM Biosciences, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.